샘플 요청 목록

 카트 문의
시장보고서
상품코드
1782975

세계의 OVD(점탄성 물질) 시장

Ophthalmic Viscosurgical Devices
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 375 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

OVD(점탄성 물질) 세계 시장은 2030년까지 5억 6,430만 달러에 달할 전망

2024년에 4억 2,980만 달러로 추정되는 OVD(점탄성 물질) 세계 시장은 2030년에는 5억 6,430만 달러에 달하고, 분석 기간인 2024-2030년 CAGR은 4.6%로 성장할 것으로 예측됩니다. 이 보고서에서 분석한 부문 중 하나인 분산형 OVD(점탄성 물질)는 CAGR 3.6%를 기록하며 분석 기간 종료시에는 2억 9,380만 달러에 달할 것으로 예측됩니다. 응집성 OVD(점탄성 물질) 분야의 성장률은 분석 기간 동안 CAGR 6.0%로 추정됩니다.

미국 시장은 1억 1,710만 달러로 추정, 중국은 CAGR 7.2%로 성장 예측

미국의 OVD(점탄성 물질) 시장은 2024년에 1억 1,710만 달러로 추정됩니다. 세계 2위 경제 대국인 중국은 분석 기간인 2024-2030년 CAGR 7.2%로 2030년까지 1억 960만 달러의 시장 규모에 달할 것으로 예측됩니다. 기타 주목할 만한 지역별 시장으로는 일본과 캐나다가 있고, 분석 기간 동안 CAGR은 각각 2.3%와 4.6%로 예측됩니다. 유럽에서는 독일이 CAGR 2.9%로 성장할 것으로 예측됩니다.

세계의 OVD(점탄성 물질) 시장 - 주요 동향과 촉진요인 정리

현대 안과 수술에 점액 수술 장비가 필수적인 이유는 무엇일까?

OVD(점탄성 물질)는 수술 중 중요한 지지체를 제공함으로써 안과 수술, 특히 백내장 수술의 핵심으로 자리매김하고 있습니다. 일반적으로 히알루론산나트륨 및 기타 점탄성 화합물로 구성된 이 겔형 물질은 전방의 안정성을 유지하고, 안구 내 조직을 보호하며, 인공수정체(IOL)의 이식을 용이하게 하는 데 필수적입니다. 백내장 수술은 전 세계적으로 가장 빈번하게 시행되는 수술 중 하나이며, 이에 따라 신뢰할 수 있는 고성능 OVD에 대한 수요도 지속적으로 증가하고 있습니다. 녹내장 필터 수술, 각막이식, 망막유리체 수술과 같은 복잡한 수술에서는 조직 보호와 공간 유지가 중요하기 때문에 그 역할이 더욱 중요해집니다. 수술 기법이 미세 절개 및 펨토초 레이저 지원 기법으로 진화함에 따라 고순도, 상동특이적 OVD에 대한 의존도가 높아지고 있습니다. 이러한 추세는 전 세계 노령인구의 증가로 인해 노화와 관련된 안과적 의료 개입이 필요한 환자층이 확대되고 있습니다. 또한, 수술 후 결과와 환자의 안전이 지속적으로 강조되면서 외과의사들은 내피 손상과 염증을 억제하는 첨단 OVD를 채택하고 있습니다. 따라서 이러한 장치는 수술 측면에서 필수적일 뿐만 아니라 시력 결과 및 회복 프로파일 개선에 초점을 맞춘 프로토콜에 점점 더 많이 통합되고 있습니다.

제품 혁신은 어떻게 OVD의 성능을 향상시키는가?

OVD(점탄성 물질)의 기술 혁신은 수술의 정확성, 안전성, 효율성을 재구축하고 있습니다. 가장 중요한 발전 중 하나는 한 번의 적용으로 공간 유지와 조직 보호의 이점을 모두 제공하는 이중 기능 OVD의 개발입니다. 이러한 제제는 수술 과정을 간소화하고 여러 제품을 투여할 필요성을 줄여줍니다. 또한, 제조업체는 점탄성체의 분자 구조를 개선하고, 유동 역학을 개선하고, 투명성을 높이고, 전방 내 체류성을 높였습니다. 이러한 개선으로 특히 소동공이나 홍채축소증(floppy iris syndrome)과 같은 복잡한 케이스에서 초음파 유화흡입술이나 인공수정체 삽입 시 안구 구조를 보다 적절하게 조작할 수 있게 되었습니다. 또한, 미리 채워진 주사기 및 인체공학적 전달 시스템을 도입하여 시술 중 취급을 개선하고 폐기물을 최소화합니다. 가교 히알루론산 제제의 발전은 장기간 유지 및 스트레스 하에서 더 나은 점탄성 거동에 기여하여 최신 고속 수술 절차의 요구에 부합합니다. 생체적합성은 여전히 주요 관심 분야이며, 염증, 안압 상승 및 수술 후 합병증 위험을 더욱 줄이기 위한 기술 혁신이 이루어지고 있습니다. 또한, 수술 중 기계적 및 약리학적 이점을 제공할 수 있는 생분해성 OVD와 약물 용출성 OVD에 대한 연구도 진행 중입니다. 이러한 기술적 진보는 수술 결과를 향상시킬 뿐만 아니라, 경쟁 시장 상황에서의 차별화로 이어지고 있습니다.

수요 패턴을 결정하는 최종사용자 및 지역 동향은?

OVD(점탄성 물질)에 대한 수요는 최종사용자의 선호도와 지역 의료 발전의 영향을 많이 받고 있습니다. 수술 인프라가 발달하고 환자의 기대치가 높은 고소득 국가에서는 안과 의사들이 성능과 안전성을 높인 프리미엄 OVD를 선호하는 경향이 강해지고 있습니다. 미국, 독일, 일본 등 국가에서는 안과 센터가 잘 정비되어 있고, 수술 건수가 많기 때문에 고급 브랜드 OVD의 안정적인 소비가 보장됩니다. 반면, 인도, 브라질, 동남아시아 등 신흥 시장에서는 백내장 수술 건수 증가, 의료 접근성 개선, 정부의 실명 예방 이니셔티브 등을 배경으로 급속한 도입이 진행되고 있습니다. 이들 지역에서는 대규모 안과 의료 프로그램 및 이동식 수술 캠프를 지원하기 위해 비용 효율적이고 신뢰할 수 있는 OVD가 요구되고 있습니다. 외래 수술 센터 및 독립형 안과 클리닉의 증가로 신속한 교체가 가능하고 오염 위험을 줄이는 멸균 일회용 OVD의 구매층이 확대되고 있습니다. 학술 기관과 수술 교육 센터는 표준화된 수술 교육 프로토콜에 OVD 사용을 통합하고 있어 수요에 더욱 기여하고 있습니다. 또한, 사모펀드가 지원하는 안과 체인 및 프랜차이즈 비전 케어 네트워크의 부상은 OVD 브랜드의 집중적인 조달과 표준화로 이어져 대형 제조업체의 시장 인지도를 높이고 있습니다. 이러한 추세는 다양한 시장 계층에서 보다 전략적이고 정량적인 구매 행동으로의 명확한 전환을 강조하고 있습니다.

OVD(점탄성 물질) 시장의 성장을 촉진하는 주요 요인은 무엇인가?

OVD(점탄성 물질) 시장의 성장은 기술 개선, 수술 건수 확대, 임상 진료 기준의 변화와 관련된 몇 가지 요인에 의해 이루어집니다. 주요 성장 요인 중 하나는 평균 수명의 증가와 조기 시력 회복 옵션에 대한 인식이 높아짐에 따라 전 세계적으로 백내장 수술이 증가하고 있다는 점입니다. 최소침습 수술과 레이저 보조 수술로의 전환으로 수술 중 빠른 상황에서도 유지력, 투명성, 챔버 안정성을 높이는 OVD에 대한 수요가 증가하고 있습니다. 일회용, 무균, 사전 충전된 OVD에 대한 최종사용자 수요도 외래 수술 센터 및 고처리량 수술 센터를 중심으로 증가하고 있습니다. 이중상 OVD, 점도 적응형 OVD 등 지속적인 제품 혁신을 통해 표준 렌즈 이식부터 고급 전방 및 후방 분절화까지 다양한 수술 시나리오에서 임상적 유용성이 확대되고 있습니다. 신흥 시장에서는 공중 보건 프로그램, 비정부 주도, 이동식 수술실 등을 통한 시력 관리 접근성 확대가 OVD의 대량 소비를 촉진하고 있습니다. 또한, 안과 장비 제조업체와 제약회사의 전략적 제휴를 통해 제품 번들 및 통합 수술 제공이 강화되고 있습니다. 안과 교육 프로그램 및 시뮬레이션 기반 교육이 확산됨에 따라 OVD의 고급 사용법에 대한 개업의들의 숙련도와 신뢰도가 높아지고 있습니다. 이러한 복합적인 요인으로 인해 OVD(점탄성 물질)는 전 세계 안과 의료에서 중요한 성장 요소로 자리 잡고 있습니다.

부문

유형(분산성, 응집성, 점착성), 공급원(생물 유래, 동물 유래, 반합성 유래), 용도(백내장 수술 용도, 각막이식 용도, 녹내장 수술 용도, 유리체망막 이식 용도)

조사 대상 기업 사례

  • Advin Health Care
  • Alcon Inc.
  • Altacor Limited
  • Amring Pharmaceuticals Inc.
  • Bausch & Lomb Incorporated
  • Beaver-Visitec International Inc.
  • Bloomage Biotechnology Corporation Limited
  • Bohus Biotech AB
  • Carl Zeiss Meditec AG
  • CIMA Technology Inc.
  • Eyebright Medical Technology Co., Ltd.
  • Eyekon Medical Inc.
  • Haohai Biological Technology
  • Johnson & Johnson Surgical Vision, Inc.
  • Maxigen Biotech Inc.
  • Ophtechnics Unlimited
  • Rayner Intraocular Lenses Limited
  • RUMEX International Co.
  • Santen Pharmaceutical Co., Ltd.
  • Truviz Ophthalmic

AI 통합

Global Industry Analysts는 검증된 전문가 컨텐츠와 AI 툴을 통해 시장 정보와 경쟁 정보를 혁신하고 있습니다.

Global Industry Analysts는 LLM 및 업계 고유의 SLM을 조회하는 일반적인 규범을 따르는 대신 비디오 기록, 블로그, 검색 엔진 조사, 방대한 양의 기업, 제품/서비스, 시장 데이터 등 세계 전문가로부터 수집한 컨텐츠 리포지토리를 구축했습니다.

관세 영향 계수

Global Industry Analysts는 본사 소재지, 제조거점, 수출입(완제품 및 OEM)을 기준으로 기업의 경쟁력 변화를 예측하고 있습니다. 이러한 복잡하고 다면적인 시장 역학은 매출원가(COGS) 증가, 수익성 하락, 공급망 재편 등 미시적, 거시적 시장 역학 중에서도 특히 경쟁사들에게 영향을 미칠 것으로 예상됩니다.

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트
  • 기타 중동
  • 아프리카

제4장 경쟁

KSM 25.08.12

Global Ophthalmic Viscosurgical Devices Market to Reach US$564.3 Million by 2030

The global market for Ophthalmic Viscosurgical Devices estimated at US$429.8 Million in the year 2024, is expected to reach US$564.3 Million by 2030, growing at a CAGR of 4.6% over the analysis period 2024-2030. Dispersive Ophthalmic Viscosurgical Devices, one of the segments analyzed in the report, is expected to record a 3.6% CAGR and reach US$293.8 Million by the end of the analysis period. Growth in the Cohesive Ophthalmic Viscosurgical Devices segment is estimated at 6.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$117.1 Million While China is Forecast to Grow at 7.2% CAGR

The Ophthalmic Viscosurgical Devices market in the U.S. is estimated at US$117.1 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$109.6 Million by the year 2030 trailing a CAGR of 7.2% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.3% and 4.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.9% CAGR.

Global Ophthalmic Viscosurgical Devices Market - Key Trends & Drivers Summarized

Why Are Viscosurgical Devices Indispensable in Modern Ocular Surgery?

Ophthalmic Viscosurgical Devices (OVDs) have established themselves as a cornerstone in ocular surgeries, particularly cataract procedures, by offering critical intraoperative support. These gel-like substances, typically composed of sodium hyaluronate or other viscoelastic compounds, are essential in maintaining anterior chamber stability, protecting intraocular tissues, and facilitating intraocular lens (IOL) implantation. With cataract surgery being one of the most frequently performed procedures worldwide, the demand for reliable and high-performing OVDs continues to grow in parallel. Their role is even more vital in complex surgeries such as glaucoma filtering procedures, corneal transplants, and vitreoretinal interventions, where tissue protection and space maintenance are critical. As surgical techniques evolve toward micro-incisional and femtosecond laser-assisted procedures, the reliance on high-purity, phase-specific OVDs is increasing. This trend is reinforced by the rising geriatric population globally, which presents a larger pool of patients requiring age-related eye care interventions. Moreover, the consistent emphasis on post-operative outcomes and patient safety is pushing surgeons to adopt advanced OVDs that reduce endothelial damage and inflammation. Thus, these devices are not only essential from a surgical standpoint but are also becoming increasingly integrated into protocols focused on improving visual outcomes and recovery profiles.

How Is Product Innovation Elevating the Performance of OVDs?

Innovation in ophthalmic viscosurgical devices is reshaping surgical precision, safety, and efficiency. One of the most significant advancements is the development of dual-function OVDs-also known as dispersive-cohesive combinations-which offer the benefits of both space maintenance and tissue protection in a single application. These formulations simplify the surgical process and reduce the need for multiple product administrations. Manufacturers are also refining the molecular structure of viscoelastics to improve flow dynamics, increase transparency, and enhance retention within the anterior chamber. These improvements allow for better manipulation of ocular structures during phacoemulsification and IOL placement, particularly in complex cases such as small pupil or floppy iris syndrome. Additionally, pre-filled syringes and ergonomic delivery systems are being introduced to improve handling and minimize waste during procedures. Advances in cross-linked hyaluronic acid formulations are contributing to prolonged retention and better viscoelastic behavior under stress, aligning with the needs of modern, high-speed surgical techniques. Biocompatibility remains a major focus area, with innovations aiming to further reduce the risk of inflammation, IOP spikes, and post-op complications. Furthermore, research is ongoing into biodegradable and drug-eluting OVDs that could provide both mechanical and pharmacological benefits intraoperatively. These technological strides are not only boosting surgical outcomes but are also creating differentiation in a competitive market landscape.

What End-Use and Geographic Trends Are Defining Demand Patterns?

Demand for ophthalmic viscosurgical devices is being strongly influenced by both end-user preferences and regional healthcare developments. In high-income countries, where surgical infrastructure is advanced and patient expectations are high, ophthalmic surgeons increasingly prefer premium OVDs that offer enhanced performance and safety. The presence of well-established ophthalmology centers and high surgical throughput in countries like the U.S., Germany, and Japan ensures steady consumption of high-grade, branded OVDs. In contrast, emerging markets such as India, Brazil, and parts of Southeast Asia are witnessing rapid adoption driven by rising cataract surgery volumes, improved healthcare access, and government-backed blindness prevention initiatives. In these regions, cost-effective yet reliable OVDs are in demand to support high-volume eye care programs and mobile surgical camps. The increasing number of ambulatory surgical centers and standalone eye clinics is also expanding the buyer base for single-use, pre-sterilized OVDs that enable fast turnover and reduce the risk of contamination. Academic institutions and surgical training centers further contribute to demand as they incorporate OVD use into standardized surgical education protocols. Additionally, the rise of private equity-backed ophthalmology chains and franchised vision care networks is leading to centralized procurement and standardization of OVD brands, increasing market visibility for leading manufacturers. These trends underscore a clear shift toward more strategic and volume-driven purchasing behavior across different market tiers.

What Key Forces Are Fueling Growth in the Ophthalmic Viscosurgical Devices Market?

The growth in the ophthalmic viscosurgical devices market is driven by several factors related to technological refinement, surgical volume expansion, and shifts in clinical practice standards. One of the primary growth drivers is the global increase in cataract surgeries, supported by rising life expectancy and growing awareness of early vision restoration options. The transition toward minimally invasive and laser-assisted surgical techniques is increasing demand for OVDs that offer enhanced retention, clarity, and chamber stability under rapid intraoperative conditions. End-user demand for single-use, sterile, and pre-filled OVD formats is also growing, especially in ambulatory and high-throughput surgical centers. Continued product innovation, including dual-phase and viscoadaptive OVDs, is expanding clinical utility across a broader range of surgical scenarios, from standard lens implantation to advanced anterior and posterior segment procedures. In emerging markets, the expansion of vision care access through public health programs, non-governmental initiatives, and mobile surgical units is driving significant volumes of OVD consumption. Additionally, strategic collaborations between ophthalmic equipment manufacturers and pharmaceutical companies are enhancing product bundling and integrated surgical offerings. The growing penetration of training programs and simulation-based education in ophthalmology is increasing practitioner familiarity and confidence with advanced OVD usage. These combined factors are positioning ophthalmic viscosurgical devices as a critical and growing component within the broader landscape of global eye care.

SCOPE OF STUDY:

The report analyzes the Ophthalmic Viscosurgical Devices market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices, Viscoadaptive Ophthalmic Viscosurgical Devices); Source (Biological Source, Animal Source, Semi-Synthetic Source); Application (Cataract Surgery Application, Corneal Grafting Application, Glaucoma Surgery Application, Vitreoretinal Grafting Application)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 39 Featured) -

  • Advin Health Care
  • Alcon Inc.
  • Altacor Limited
  • Amring Pharmaceuticals Inc.
  • Bausch & Lomb Incorporated
  • Beaver-Visitec International Inc.
  • Bloomage Biotechnology Corporation Limited
  • Bohus Biotech AB
  • Carl Zeiss Meditec AG
  • CIMA Technology Inc.
  • Eyebright Medical Technology Co., Ltd.
  • Eyekon Medical Inc.
  • Haohai Biological Technology
  • Johnson & Johnson Surgical Vision, Inc.
  • Maxigen Biotech Inc.
  • Ophtechnics Unlimited
  • Rayner Intraocular Lenses Limited
  • RUMEX International Co.
  • Santen Pharmaceutical Co., Ltd.
  • Truviz Ophthalmic

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Ophthalmic Viscosurgical Devices - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Global Cataract Surgery Rates Throw the Spotlight on High-Performance Ophthalmic Viscosurgical Devices (OVDs)
    • Growing Geriatric Population Spur Growth in Age-Related Eye Surgeries and Long-Term Use of Viscosurgical Aids
    • Minimally Invasive Surgical Techniques Expand Addressable Market Opportunity for Low-Viscosity and Dual-Function OVDs
    • Technological Innovations in Rheological Properties Strengthen the Business Case for Advanced Cohesive and Dispersive OVDs
    • Demand for Faster Recovery and Improved Outcomes Drives Adoption of Tissue-Protective, High-Purity OVD Formulations
    • Surge in Refractive and Glaucoma Surgeries Sustains Growth in Multifunctional Viscosurgical Product Portfolios
    • Customized OVD Use in Complex Surgeries Creates Opportunities for Procedure-Specific Product Development
    • Integration of Preloaded, Single-Use Delivery Systems Propels Growth in High-Volume, Ambulatory Surgical Centers
    • Expansion of Ophthalmic Services in Emerging Economies Generates Demand for Cost-Effective, Shelf-Stable OVDs
    • Advancement in Dual-Viscosity and Viscoadaptive Technologies Drive Clinical Efficiency and Reduce Surgical Time
    • Rising Focus on Standardization and Product Training Across Eye Care Chains Spurs Greater OVD Utilization
    • Shift Toward Personalized Eye Surgery Protocols Encourages Development of Indication-Specific Viscosurgical Solutions
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Ophthalmic Viscosurgical Devices Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Ophthalmic Viscosurgical Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Ophthalmic Viscosurgical Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Dispersive Ophthalmic Viscosurgical Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Dispersive Ophthalmic Viscosurgical Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Dispersive Ophthalmic Viscosurgical Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Cohesive Ophthalmic Viscosurgical Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Cohesive Ophthalmic Viscosurgical Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Cohesive Ophthalmic Viscosurgical Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Viscoadaptive Ophthalmic Viscosurgical Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Viscoadaptive Ophthalmic Viscosurgical Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Viscoadaptive Ophthalmic Viscosurgical Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Vitreoretinal Grafting Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Vitreoretinal Grafting Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Vitreoretinal Grafting Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Cataract Surgery Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Cataract Surgery Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Cataract Surgery Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Corneal Grafting Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Corneal Grafting Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Corneal Grafting Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Glaucoma Surgery Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Glaucoma Surgery Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Glaucoma Surgery Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Biological Source by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Biological Source by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Biological Source by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Animal Source by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Animal Source by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Animal Source by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Semi-Synthetic Source by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Semi-Synthetic Source by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: World 15-Year Perspective for Semi-Synthetic Source by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Ophthalmic Viscosurgical Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 35: USA Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Type - Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Ophthalmic Viscosurgical Devices by Type - Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: USA 15-Year Perspective for Ophthalmic Viscosurgical Devices by Type - Percentage Breakdown of Value Sales for Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices for the Years 2015, 2025 & 2030
    • TABLE 38: USA Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Application - Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Ophthalmic Viscosurgical Devices by Application - Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: USA 15-Year Perspective for Ophthalmic Viscosurgical Devices by Application - Percentage Breakdown of Value Sales for Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application for the Years 2015, 2025 & 2030
    • TABLE 41: USA Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Source - Biological Source, Animal Source and Semi-Synthetic Source - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for Ophthalmic Viscosurgical Devices by Source - Biological Source, Animal Source and Semi-Synthetic Source Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: USA 15-Year Perspective for Ophthalmic Viscosurgical Devices by Source - Percentage Breakdown of Value Sales for Biological Source, Animal Source and Semi-Synthetic Source for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Type - Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Ophthalmic Viscosurgical Devices by Type - Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: Canada 15-Year Perspective for Ophthalmic Viscosurgical Devices by Type - Percentage Breakdown of Value Sales for Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices for the Years 2015, 2025 & 2030
    • TABLE 47: Canada Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Application - Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Canada Historic Review for Ophthalmic Viscosurgical Devices by Application - Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: Canada 15-Year Perspective for Ophthalmic Viscosurgical Devices by Application - Percentage Breakdown of Value Sales for Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application for the Years 2015, 2025 & 2030
    • TABLE 50: Canada Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Source - Biological Source, Animal Source and Semi-Synthetic Source - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Canada Historic Review for Ophthalmic Viscosurgical Devices by Source - Biological Source, Animal Source and Semi-Synthetic Source Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: Canada 15-Year Perspective for Ophthalmic Viscosurgical Devices by Source - Percentage Breakdown of Value Sales for Biological Source, Animal Source and Semi-Synthetic Source for the Years 2015, 2025 & 2030
  • JAPAN
    • Ophthalmic Viscosurgical Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 53: Japan Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Type - Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Japan Historic Review for Ophthalmic Viscosurgical Devices by Type - Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: Japan 15-Year Perspective for Ophthalmic Viscosurgical Devices by Type - Percentage Breakdown of Value Sales for Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices for the Years 2015, 2025 & 2030
    • TABLE 56: Japan Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Application - Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Japan Historic Review for Ophthalmic Viscosurgical Devices by Application - Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: Japan 15-Year Perspective for Ophthalmic Viscosurgical Devices by Application - Percentage Breakdown of Value Sales for Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application for the Years 2015, 2025 & 2030
    • TABLE 59: Japan Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Source - Biological Source, Animal Source and Semi-Synthetic Source - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Japan Historic Review for Ophthalmic Viscosurgical Devices by Source - Biological Source, Animal Source and Semi-Synthetic Source Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: Japan 15-Year Perspective for Ophthalmic Viscosurgical Devices by Source - Percentage Breakdown of Value Sales for Biological Source, Animal Source and Semi-Synthetic Source for the Years 2015, 2025 & 2030
  • CHINA
    • Ophthalmic Viscosurgical Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 62: China Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Type - Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: China Historic Review for Ophthalmic Viscosurgical Devices by Type - Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: China 15-Year Perspective for Ophthalmic Viscosurgical Devices by Type - Percentage Breakdown of Value Sales for Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices for the Years 2015, 2025 & 2030
    • TABLE 65: China Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Application - Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: China Historic Review for Ophthalmic Viscosurgical Devices by Application - Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: China 15-Year Perspective for Ophthalmic Viscosurgical Devices by Application - Percentage Breakdown of Value Sales for Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application for the Years 2015, 2025 & 2030
    • TABLE 68: China Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Source - Biological Source, Animal Source and Semi-Synthetic Source - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: China Historic Review for Ophthalmic Viscosurgical Devices by Source - Biological Source, Animal Source and Semi-Synthetic Source Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: China 15-Year Perspective for Ophthalmic Viscosurgical Devices by Source - Percentage Breakdown of Value Sales for Biological Source, Animal Source and Semi-Synthetic Source for the Years 2015, 2025 & 2030
  • EUROPE
    • Ophthalmic Viscosurgical Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 71: Europe Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 72: Europe Historic Review for Ophthalmic Viscosurgical Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: Europe 15-Year Perspective for Ophthalmic Viscosurgical Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Type - Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Ophthalmic Viscosurgical Devices by Type - Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: Europe 15-Year Perspective for Ophthalmic Viscosurgical Devices by Type - Percentage Breakdown of Value Sales for Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices for the Years 2015, 2025 & 2030
    • TABLE 77: Europe Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Application - Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Europe Historic Review for Ophthalmic Viscosurgical Devices by Application - Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: Europe 15-Year Perspective for Ophthalmic Viscosurgical Devices by Application - Percentage Breakdown of Value Sales for Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application for the Years 2015, 2025 & 2030
    • TABLE 80: Europe Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Source - Biological Source, Animal Source and Semi-Synthetic Source - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Europe Historic Review for Ophthalmic Viscosurgical Devices by Source - Biological Source, Animal Source and Semi-Synthetic Source Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: Europe 15-Year Perspective for Ophthalmic Viscosurgical Devices by Source - Percentage Breakdown of Value Sales for Biological Source, Animal Source and Semi-Synthetic Source for the Years 2015, 2025 & 2030
  • FRANCE
    • Ophthalmic Viscosurgical Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 83: France Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Type - Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: France Historic Review for Ophthalmic Viscosurgical Devices by Type - Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: France 15-Year Perspective for Ophthalmic Viscosurgical Devices by Type - Percentage Breakdown of Value Sales for Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices for the Years 2015, 2025 & 2030
    • TABLE 86: France Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Application - Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: France Historic Review for Ophthalmic Viscosurgical Devices by Application - Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: France 15-Year Perspective for Ophthalmic Viscosurgical Devices by Application - Percentage Breakdown of Value Sales for Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application for the Years 2015, 2025 & 2030
    • TABLE 89: France Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Source - Biological Source, Animal Source and Semi-Synthetic Source - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: France Historic Review for Ophthalmic Viscosurgical Devices by Source - Biological Source, Animal Source and Semi-Synthetic Source Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: France 15-Year Perspective for Ophthalmic Viscosurgical Devices by Source - Percentage Breakdown of Value Sales for Biological Source, Animal Source and Semi-Synthetic Source for the Years 2015, 2025 & 2030
  • GERMANY
    • Ophthalmic Viscosurgical Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 92: Germany Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Type - Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Germany Historic Review for Ophthalmic Viscosurgical Devices by Type - Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: Germany 15-Year Perspective for Ophthalmic Viscosurgical Devices by Type - Percentage Breakdown of Value Sales for Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices for the Years 2015, 2025 & 2030
    • TABLE 95: Germany Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Application - Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Germany Historic Review for Ophthalmic Viscosurgical Devices by Application - Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Germany 15-Year Perspective for Ophthalmic Viscosurgical Devices by Application - Percentage Breakdown of Value Sales for Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application for the Years 2015, 2025 & 2030
    • TABLE 98: Germany Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Source - Biological Source, Animal Source and Semi-Synthetic Source - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Germany Historic Review for Ophthalmic Viscosurgical Devices by Source - Biological Source, Animal Source and Semi-Synthetic Source Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: Germany 15-Year Perspective for Ophthalmic Viscosurgical Devices by Source - Percentage Breakdown of Value Sales for Biological Source, Animal Source and Semi-Synthetic Source for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 101: Italy Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Type - Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Italy Historic Review for Ophthalmic Viscosurgical Devices by Type - Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: Italy 15-Year Perspective for Ophthalmic Viscosurgical Devices by Type - Percentage Breakdown of Value Sales for Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices for the Years 2015, 2025 & 2030
    • TABLE 104: Italy Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Application - Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Italy Historic Review for Ophthalmic Viscosurgical Devices by Application - Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: Italy 15-Year Perspective for Ophthalmic Viscosurgical Devices by Application - Percentage Breakdown of Value Sales for Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application for the Years 2015, 2025 & 2030
    • TABLE 107: Italy Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Source - Biological Source, Animal Source and Semi-Synthetic Source - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Italy Historic Review for Ophthalmic Viscosurgical Devices by Source - Biological Source, Animal Source and Semi-Synthetic Source Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: Italy 15-Year Perspective for Ophthalmic Viscosurgical Devices by Source - Percentage Breakdown of Value Sales for Biological Source, Animal Source and Semi-Synthetic Source for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Ophthalmic Viscosurgical Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 110: UK Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Type - Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: UK Historic Review for Ophthalmic Viscosurgical Devices by Type - Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: UK 15-Year Perspective for Ophthalmic Viscosurgical Devices by Type - Percentage Breakdown of Value Sales for Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices for the Years 2015, 2025 & 2030
    • TABLE 113: UK Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Application - Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: UK Historic Review for Ophthalmic Viscosurgical Devices by Application - Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 115: UK 15-Year Perspective for Ophthalmic Viscosurgical Devices by Application - Percentage Breakdown of Value Sales for Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application for the Years 2015, 2025 & 2030
    • TABLE 116: UK Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Source - Biological Source, Animal Source and Semi-Synthetic Source - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: UK Historic Review for Ophthalmic Viscosurgical Devices by Source - Biological Source, Animal Source and Semi-Synthetic Source Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 118: UK 15-Year Perspective for Ophthalmic Viscosurgical Devices by Source - Percentage Breakdown of Value Sales for Biological Source, Animal Source and Semi-Synthetic Source for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 119: Spain Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Type - Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Spain Historic Review for Ophthalmic Viscosurgical Devices by Type - Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 121: Spain 15-Year Perspective for Ophthalmic Viscosurgical Devices by Type - Percentage Breakdown of Value Sales for Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices for the Years 2015, 2025 & 2030
    • TABLE 122: Spain Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Application - Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Spain Historic Review for Ophthalmic Viscosurgical Devices by Application - Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 124: Spain 15-Year Perspective for Ophthalmic Viscosurgical Devices by Application - Percentage Breakdown of Value Sales for Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application for the Years 2015, 2025 & 2030
    • TABLE 125: Spain Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Source - Biological Source, Animal Source and Semi-Synthetic Source - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Spain Historic Review for Ophthalmic Viscosurgical Devices by Source - Biological Source, Animal Source and Semi-Synthetic Source Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 127: Spain 15-Year Perspective for Ophthalmic Viscosurgical Devices by Source - Percentage Breakdown of Value Sales for Biological Source, Animal Source and Semi-Synthetic Source for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 128: Russia Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Type - Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Russia Historic Review for Ophthalmic Viscosurgical Devices by Type - Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 130: Russia 15-Year Perspective for Ophthalmic Viscosurgical Devices by Type - Percentage Breakdown of Value Sales for Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices for the Years 2015, 2025 & 2030
    • TABLE 131: Russia Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Application - Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Russia Historic Review for Ophthalmic Viscosurgical Devices by Application - Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 133: Russia 15-Year Perspective for Ophthalmic Viscosurgical Devices by Application - Percentage Breakdown of Value Sales for Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application for the Years 2015, 2025 & 2030
    • TABLE 134: Russia Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Source - Biological Source, Animal Source and Semi-Synthetic Source - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Russia Historic Review for Ophthalmic Viscosurgical Devices by Source - Biological Source, Animal Source and Semi-Synthetic Source Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 136: Russia 15-Year Perspective for Ophthalmic Viscosurgical Devices by Source - Percentage Breakdown of Value Sales for Biological Source, Animal Source and Semi-Synthetic Source for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 137: Rest of Europe Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Type - Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Rest of Europe Historic Review for Ophthalmic Viscosurgical Devices by Type - Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 139: Rest of Europe 15-Year Perspective for Ophthalmic Viscosurgical Devices by Type - Percentage Breakdown of Value Sales for Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices for the Years 2015, 2025 & 2030
    • TABLE 140: Rest of Europe Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Application - Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Rest of Europe Historic Review for Ophthalmic Viscosurgical Devices by Application - Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 142: Rest of Europe 15-Year Perspective for Ophthalmic Viscosurgical Devices by Application - Percentage Breakdown of Value Sales for Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application for the Years 2015, 2025 & 2030
    • TABLE 143: Rest of Europe Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Source - Biological Source, Animal Source and Semi-Synthetic Source - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Rest of Europe Historic Review for Ophthalmic Viscosurgical Devices by Source - Biological Source, Animal Source and Semi-Synthetic Source Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 145: Rest of Europe 15-Year Perspective for Ophthalmic Viscosurgical Devices by Source - Percentage Breakdown of Value Sales for Biological Source, Animal Source and Semi-Synthetic Source for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Ophthalmic Viscosurgical Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 147: Asia-Pacific Historic Review for Ophthalmic Viscosurgical Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 148: Asia-Pacific 15-Year Perspective for Ophthalmic Viscosurgical Devices by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Type - Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Asia-Pacific Historic Review for Ophthalmic Viscosurgical Devices by Type - Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 151: Asia-Pacific 15-Year Perspective for Ophthalmic Viscosurgical Devices by Type - Percentage Breakdown of Value Sales for Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices for the Years 2015, 2025 & 2030
    • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Application - Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Asia-Pacific Historic Review for Ophthalmic Viscosurgical Devices by Application - Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 154: Asia-Pacific 15-Year Perspective for Ophthalmic Viscosurgical Devices by Application - Percentage Breakdown of Value Sales for Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application for the Years 2015, 2025 & 2030
    • TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Source - Biological Source, Animal Source and Semi-Synthetic Source - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Asia-Pacific Historic Review for Ophthalmic Viscosurgical Devices by Source - Biological Source, Animal Source and Semi-Synthetic Source Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 157: Asia-Pacific 15-Year Perspective for Ophthalmic Viscosurgical Devices by Source - Percentage Breakdown of Value Sales for Biological Source, Animal Source and Semi-Synthetic Source for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Ophthalmic Viscosurgical Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 158: Australia Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Type - Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Australia Historic Review for Ophthalmic Viscosurgical Devices by Type - Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 160: Australia 15-Year Perspective for Ophthalmic Viscosurgical Devices by Type - Percentage Breakdown of Value Sales for Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices for the Years 2015, 2025 & 2030
    • TABLE 161: Australia Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Application - Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Australia Historic Review for Ophthalmic Viscosurgical Devices by Application - Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 163: Australia 15-Year Perspective for Ophthalmic Viscosurgical Devices by Application - Percentage Breakdown of Value Sales for Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application for the Years 2015, 2025 & 2030
    • TABLE 164: Australia Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Source - Biological Source, Animal Source and Semi-Synthetic Source - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Australia Historic Review for Ophthalmic Viscosurgical Devices by Source - Biological Source, Animal Source and Semi-Synthetic Source Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 166: Australia 15-Year Perspective for Ophthalmic Viscosurgical Devices by Source - Percentage Breakdown of Value Sales for Biological Source, Animal Source and Semi-Synthetic Source for the Years 2015, 2025 & 2030
  • INDIA
    • Ophthalmic Viscosurgical Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 167: India Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Type - Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 168: India Historic Review for Ophthalmic Viscosurgical Devices by Type - Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 169: India 15-Year Perspective for Ophthalmic Viscosurgical Devices by Type - Percentage Breakdown of Value Sales for Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices for the Years 2015, 2025 & 2030
    • TABLE 170: India Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Application - Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 171: India Historic Review for Ophthalmic Viscosurgical Devices by Application - Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 172: India 15-Year Perspective for Ophthalmic Viscosurgical Devices by Application - Percentage Breakdown of Value Sales for Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application for the Years 2015, 2025 & 2030
    • TABLE 173: India Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Source - Biological Source, Animal Source and Semi-Synthetic Source - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 174: India Historic Review for Ophthalmic Viscosurgical Devices by Source - Biological Source, Animal Source and Semi-Synthetic Source Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 175: India 15-Year Perspective for Ophthalmic Viscosurgical Devices by Source - Percentage Breakdown of Value Sales for Biological Source, Animal Source and Semi-Synthetic Source for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 176: South Korea Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Type - Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 177: South Korea Historic Review for Ophthalmic Viscosurgical Devices by Type - Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 178: South Korea 15-Year Perspective for Ophthalmic Viscosurgical Devices by Type - Percentage Breakdown of Value Sales for Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices for the Years 2015, 2025 & 2030
    • TABLE 179: South Korea Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Application - Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 180: South Korea Historic Review for Ophthalmic Viscosurgical Devices by Application - Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 181: South Korea 15-Year Perspective for Ophthalmic Viscosurgical Devices by Application - Percentage Breakdown of Value Sales for Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application for the Years 2015, 2025 & 2030
    • TABLE 182: South Korea Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Source - Biological Source, Animal Source and Semi-Synthetic Source - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: South Korea Historic Review for Ophthalmic Viscosurgical Devices by Source - Biological Source, Animal Source and Semi-Synthetic Source Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 184: South Korea 15-Year Perspective for Ophthalmic Viscosurgical Devices by Source - Percentage Breakdown of Value Sales for Biological Source, Animal Source and Semi-Synthetic Source for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 185: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Type - Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Rest of Asia-Pacific Historic Review for Ophthalmic Viscosurgical Devices by Type - Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 187: Rest of Asia-Pacific 15-Year Perspective for Ophthalmic Viscosurgical Devices by Type - Percentage Breakdown of Value Sales for Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices for the Years 2015, 2025 & 2030
    • TABLE 188: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Application - Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Rest of Asia-Pacific Historic Review for Ophthalmic Viscosurgical Devices by Application - Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 190: Rest of Asia-Pacific 15-Year Perspective for Ophthalmic Viscosurgical Devices by Application - Percentage Breakdown of Value Sales for Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application for the Years 2015, 2025 & 2030
    • TABLE 191: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Source - Biological Source, Animal Source and Semi-Synthetic Source - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Rest of Asia-Pacific Historic Review for Ophthalmic Viscosurgical Devices by Source - Biological Source, Animal Source and Semi-Synthetic Source Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 193: Rest of Asia-Pacific 15-Year Perspective for Ophthalmic Viscosurgical Devices by Source - Percentage Breakdown of Value Sales for Biological Source, Animal Source and Semi-Synthetic Source for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Ophthalmic Viscosurgical Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 194: Latin America Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 195: Latin America Historic Review for Ophthalmic Viscosurgical Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 196: Latin America 15-Year Perspective for Ophthalmic Viscosurgical Devices by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 197: Latin America Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Type - Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Latin America Historic Review for Ophthalmic Viscosurgical Devices by Type - Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 199: Latin America 15-Year Perspective for Ophthalmic Viscosurgical Devices by Type - Percentage Breakdown of Value Sales for Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices for the Years 2015, 2025 & 2030
    • TABLE 200: Latin America Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Application - Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Latin America Historic Review for Ophthalmic Viscosurgical Devices by Application - Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 202: Latin America 15-Year Perspective for Ophthalmic Viscosurgical Devices by Application - Percentage Breakdown of Value Sales for Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application for the Years 2015, 2025 & 2030
    • TABLE 203: Latin America Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Source - Biological Source, Animal Source and Semi-Synthetic Source - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Latin America Historic Review for Ophthalmic Viscosurgical Devices by Source - Biological Source, Animal Source and Semi-Synthetic Source Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 205: Latin America 15-Year Perspective for Ophthalmic Viscosurgical Devices by Source - Percentage Breakdown of Value Sales for Biological Source, Animal Source and Semi-Synthetic Source for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 206: Argentina Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Type - Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Argentina Historic Review for Ophthalmic Viscosurgical Devices by Type - Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 208: Argentina 15-Year Perspective for Ophthalmic Viscosurgical Devices by Type - Percentage Breakdown of Value Sales for Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices for the Years 2015, 2025 & 2030
    • TABLE 209: Argentina Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Application - Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Argentina Historic Review for Ophthalmic Viscosurgical Devices by Application - Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 211: Argentina 15-Year Perspective for Ophthalmic Viscosurgical Devices by Application - Percentage Breakdown of Value Sales for Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application for the Years 2015, 2025 & 2030
    • TABLE 212: Argentina Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Source - Biological Source, Animal Source and Semi-Synthetic Source - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Argentina Historic Review for Ophthalmic Viscosurgical Devices by Source - Biological Source, Animal Source and Semi-Synthetic Source Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 214: Argentina 15-Year Perspective for Ophthalmic Viscosurgical Devices by Source - Percentage Breakdown of Value Sales for Biological Source, Animal Source and Semi-Synthetic Source for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 215: Brazil Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Type - Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Brazil Historic Review for Ophthalmic Viscosurgical Devices by Type - Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 217: Brazil 15-Year Perspective for Ophthalmic Viscosurgical Devices by Type - Percentage Breakdown of Value Sales for Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices for the Years 2015, 2025 & 2030
    • TABLE 218: Brazil Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Application - Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 219: Brazil Historic Review for Ophthalmic Viscosurgical Devices by Application - Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 220: Brazil 15-Year Perspective for Ophthalmic Viscosurgical Devices by Application - Percentage Breakdown of Value Sales for Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application for the Years 2015, 2025 & 2030
    • TABLE 221: Brazil Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Source - Biological Source, Animal Source and Semi-Synthetic Source - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 222: Brazil Historic Review for Ophthalmic Viscosurgical Devices by Source - Biological Source, Animal Source and Semi-Synthetic Source Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 223: Brazil 15-Year Perspective for Ophthalmic Viscosurgical Devices by Source - Percentage Breakdown of Value Sales for Biological Source, Animal Source and Semi-Synthetic Source for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 224: Mexico Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Type - Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 225: Mexico Historic Review for Ophthalmic Viscosurgical Devices by Type - Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 226: Mexico 15-Year Perspective for Ophthalmic Viscosurgical Devices by Type - Percentage Breakdown of Value Sales for Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices for the Years 2015, 2025 & 2030
    • TABLE 227: Mexico Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Application - Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 228: Mexico Historic Review for Ophthalmic Viscosurgical Devices by Application - Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 229: Mexico 15-Year Perspective for Ophthalmic Viscosurgical Devices by Application - Percentage Breakdown of Value Sales for Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application for the Years 2015, 2025 & 2030
    • TABLE 230: Mexico Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Source - Biological Source, Animal Source and Semi-Synthetic Source - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 231: Mexico Historic Review for Ophthalmic Viscosurgical Devices by Source - Biological Source, Animal Source and Semi-Synthetic Source Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 232: Mexico 15-Year Perspective for Ophthalmic Viscosurgical Devices by Source - Percentage Breakdown of Value Sales for Biological Source, Animal Source and Semi-Synthetic Source for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 233: Rest of Latin America Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Type - Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 234: Rest of Latin America Historic Review for Ophthalmic Viscosurgical Devices by Type - Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 235: Rest of Latin America 15-Year Perspective for Ophthalmic Viscosurgical Devices by Type - Percentage Breakdown of Value Sales for Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices for the Years 2015, 2025 & 2030
    • TABLE 236: Rest of Latin America Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Application - Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 237: Rest of Latin America Historic Review for Ophthalmic Viscosurgical Devices by Application - Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 238: Rest of Latin America 15-Year Perspective for Ophthalmic Viscosurgical Devices by Application - Percentage Breakdown of Value Sales for Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application for the Years 2015, 2025 & 2030
    • TABLE 239: Rest of Latin America Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Source - Biological Source, Animal Source and Semi-Synthetic Source - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 240: Rest of Latin America Historic Review for Ophthalmic Viscosurgical Devices by Source - Biological Source, Animal Source and Semi-Synthetic Source Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 241: Rest of Latin America 15-Year Perspective for Ophthalmic Viscosurgical Devices by Source - Percentage Breakdown of Value Sales for Biological Source, Animal Source and Semi-Synthetic Source for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Ophthalmic Viscosurgical Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 242: Middle East Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 243: Middle East Historic Review for Ophthalmic Viscosurgical Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 244: Middle East 15-Year Perspective for Ophthalmic Viscosurgical Devices by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 245: Middle East Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Type - Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 246: Middle East Historic Review for Ophthalmic Viscosurgical Devices by Type - Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 247: Middle East 15-Year Perspective for Ophthalmic Viscosurgical Devices by Type - Percentage Breakdown of Value Sales for Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices for the Years 2015, 2025 & 2030
    • TABLE 248: Middle East Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Application - Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 249: Middle East Historic Review for Ophthalmic Viscosurgical Devices by Application - Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 250: Middle East 15-Year Perspective for Ophthalmic Viscosurgical Devices by Application - Percentage Breakdown of Value Sales for Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application for the Years 2015, 2025 & 2030
    • TABLE 251: Middle East Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Source - Biological Source, Animal Source and Semi-Synthetic Source - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 252: Middle East Historic Review for Ophthalmic Viscosurgical Devices by Source - Biological Source, Animal Source and Semi-Synthetic Source Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 253: Middle East 15-Year Perspective for Ophthalmic Viscosurgical Devices by Source - Percentage Breakdown of Value Sales for Biological Source, Animal Source and Semi-Synthetic Source for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 254: Iran Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Type - Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 255: Iran Historic Review for Ophthalmic Viscosurgical Devices by Type - Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 256: Iran 15-Year Perspective for Ophthalmic Viscosurgical Devices by Type - Percentage Breakdown of Value Sales for Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices for the Years 2015, 2025 & 2030
    • TABLE 257: Iran Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Application - Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 258: Iran Historic Review for Ophthalmic Viscosurgical Devices by Application - Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 259: Iran 15-Year Perspective for Ophthalmic Viscosurgical Devices by Application - Percentage Breakdown of Value Sales for Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application for the Years 2015, 2025 & 2030
    • TABLE 260: Iran Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Source - Biological Source, Animal Source and Semi-Synthetic Source - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 261: Iran Historic Review for Ophthalmic Viscosurgical Devices by Source - Biological Source, Animal Source and Semi-Synthetic Source Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 262: Iran 15-Year Perspective for Ophthalmic Viscosurgical Devices by Source - Percentage Breakdown of Value Sales for Biological Source, Animal Source and Semi-Synthetic Source for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 263: Israel Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Type - Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 264: Israel Historic Review for Ophthalmic Viscosurgical Devices by Type - Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 265: Israel 15-Year Perspective for Ophthalmic Viscosurgical Devices by Type - Percentage Breakdown of Value Sales for Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices for the Years 2015, 2025 & 2030
    • TABLE 266: Israel Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Application - Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 267: Israel Historic Review for Ophthalmic Viscosurgical Devices by Application - Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 268: Israel 15-Year Perspective for Ophthalmic Viscosurgical Devices by Application - Percentage Breakdown of Value Sales for Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application for the Years 2015, 2025 & 2030
    • TABLE 269: Israel Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Source - Biological Source, Animal Source and Semi-Synthetic Source - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 270: Israel Historic Review for Ophthalmic Viscosurgical Devices by Source - Biological Source, Animal Source and Semi-Synthetic Source Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 271: Israel 15-Year Perspective for Ophthalmic Viscosurgical Devices by Source - Percentage Breakdown of Value Sales for Biological Source, Animal Source and Semi-Synthetic Source for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 272: Saudi Arabia Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Type - Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 273: Saudi Arabia Historic Review for Ophthalmic Viscosurgical Devices by Type - Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 274: Saudi Arabia 15-Year Perspective for Ophthalmic Viscosurgical Devices by Type - Percentage Breakdown of Value Sales for Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices for the Years 2015, 2025 & 2030
    • TABLE 275: Saudi Arabia Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Application - Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 276: Saudi Arabia Historic Review for Ophthalmic Viscosurgical Devices by Application - Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 277: Saudi Arabia 15-Year Perspective for Ophthalmic Viscosurgical Devices by Application - Percentage Breakdown of Value Sales for Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application for the Years 2015, 2025 & 2030
    • TABLE 278: Saudi Arabia Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Source - Biological Source, Animal Source and Semi-Synthetic Source - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 279: Saudi Arabia Historic Review for Ophthalmic Viscosurgical Devices by Source - Biological Source, Animal Source and Semi-Synthetic Source Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 280: Saudi Arabia 15-Year Perspective for Ophthalmic Viscosurgical Devices by Source - Percentage Breakdown of Value Sales for Biological Source, Animal Source and Semi-Synthetic Source for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 281: UAE Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Type - Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 282: UAE Historic Review for Ophthalmic Viscosurgical Devices by Type - Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 283: UAE 15-Year Perspective for Ophthalmic Viscosurgical Devices by Type - Percentage Breakdown of Value Sales for Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices for the Years 2015, 2025 & 2030
    • TABLE 284: UAE Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Application - Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 285: UAE Historic Review for Ophthalmic Viscosurgical Devices by Application - Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 286: UAE 15-Year Perspective for Ophthalmic Viscosurgical Devices by Application - Percentage Breakdown of Value Sales for Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application for the Years 2015, 2025 & 2030
    • TABLE 287: UAE Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Source - Biological Source, Animal Source and Semi-Synthetic Source - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 288: UAE Historic Review for Ophthalmic Viscosurgical Devices by Source - Biological Source, Animal Source and Semi-Synthetic Source Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 289: UAE 15-Year Perspective for Ophthalmic Viscosurgical Devices by Source - Percentage Breakdown of Value Sales for Biological Source, Animal Source and Semi-Synthetic Source for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 290: Rest of Middle East Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Type - Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 291: Rest of Middle East Historic Review for Ophthalmic Viscosurgical Devices by Type - Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 292: Rest of Middle East 15-Year Perspective for Ophthalmic Viscosurgical Devices by Type - Percentage Breakdown of Value Sales for Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices for the Years 2015, 2025 & 2030
    • TABLE 293: Rest of Middle East Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Application - Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 294: Rest of Middle East Historic Review for Ophthalmic Viscosurgical Devices by Application - Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 295: Rest of Middle East 15-Year Perspective for Ophthalmic Viscosurgical Devices by Application - Percentage Breakdown of Value Sales for Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application for the Years 2015, 2025 & 2030
    • TABLE 296: Rest of Middle East Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Source - Biological Source, Animal Source and Semi-Synthetic Source - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 297: Rest of Middle East Historic Review for Ophthalmic Viscosurgical Devices by Source - Biological Source, Animal Source and Semi-Synthetic Source Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 298: Rest of Middle East 15-Year Perspective for Ophthalmic Viscosurgical Devices by Source - Percentage Breakdown of Value Sales for Biological Source, Animal Source and Semi-Synthetic Source for the Years 2015, 2025 & 2030
  • AFRICA
    • Ophthalmic Viscosurgical Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 299: Africa Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Type - Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 300: Africa Historic Review for Ophthalmic Viscosurgical Devices by Type - Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 301: Africa 15-Year Perspective for Ophthalmic Viscosurgical Devices by Type - Percentage Breakdown of Value Sales for Dispersive Ophthalmic Viscosurgical Devices, Cohesive Ophthalmic Viscosurgical Devices and Viscoadaptive Ophthalmic Viscosurgical Devices for the Years 2015, 2025 & 2030
    • TABLE 302: Africa Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Application - Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 303: Africa Historic Review for Ophthalmic Viscosurgical Devices by Application - Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 304: Africa 15-Year Perspective for Ophthalmic Viscosurgical Devices by Application - Percentage Breakdown of Value Sales for Vitreoretinal Grafting Application, Cataract Surgery Application, Corneal Grafting Application and Glaucoma Surgery Application for the Years 2015, 2025 & 2030
    • TABLE 305: Africa Recent Past, Current & Future Analysis for Ophthalmic Viscosurgical Devices by Source - Biological Source, Animal Source and Semi-Synthetic Source - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 306: Africa Historic Review for Ophthalmic Viscosurgical Devices by Source - Biological Source, Animal Source and Semi-Synthetic Source Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 307: Africa 15-Year Perspective for Ophthalmic Viscosurgical Devices by Source - Percentage Breakdown of Value Sales for Biological Source, Animal Source and Semi-Synthetic Source for the Years 2015, 2025 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제